J. David Leander

6.0k total citations
167 papers, 5.1k citations indexed

About

J. David Leander is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Animal Science and Zoology. According to data from OpenAlex, J. David Leander has authored 167 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Cellular and Molecular Neuroscience, 57 papers in Molecular Biology and 37 papers in Animal Science and Zoology. Recurrent topics in J. David Leander's work include Neurotransmitter Receptor Influence on Behavior (37 papers), Neuroscience and Neuropharmacology Research (37 papers) and Receptor Mechanisms and Signaling (29 papers). J. David Leander is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (37 papers), Neuroscience and Neuropharmacology Research (37 papers) and Receptor Mechanisms and Signaling (29 papers). J. David Leander collaborates with scholars based in United States, United Kingdom and Austria. J. David Leander's co-authors include D. E. McMillan, Dennis M. Zimmerman, Robert L. Balster, Mary C. Wolff, J. Willetts, Paul L. Ornstein, David W. Robertson, David Lodge, M. Brian Arnold and Darryle D. Schoepp and has published in prestigious journals such as Biological Psychiatry, Brain Research and Pain.

In The Last Decade

J. David Leander

166 papers receiving 4.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. David Leander United States 40 3.2k 2.3k 641 610 560 167 5.1k
C. J. E. Niemegeers Belgium 44 4.0k 1.3× 2.7k 1.2× 610 1.0× 665 1.1× 885 1.6× 148 7.5k
John A. Rosecrans United States 38 3.0k 1.0× 2.0k 0.9× 326 0.5× 475 0.8× 824 1.5× 145 4.5k
James H. Woods United States 38 2.7k 0.8× 1.5k 0.7× 181 0.3× 529 0.9× 504 0.9× 138 4.3k
W. Haefely Switzerland 47 5.3k 1.7× 2.6k 1.1× 577 0.9× 700 1.1× 864 1.5× 137 8.1k
James H. Woods United States 47 4.5k 1.4× 2.9k 1.3× 178 0.3× 871 1.4× 1.2k 2.2× 217 6.7k
B. Kenneth Koe United States 24 2.5k 0.8× 1.7k 0.7× 916 1.4× 546 0.9× 493 0.9× 79 4.7k
Edward F. Domino United States 38 2.7k 0.8× 1.8k 0.8× 148 0.2× 730 1.2× 684 1.2× 155 5.1k
Barrett R. Cooper United States 35 2.5k 0.8× 1.4k 0.6× 368 0.6× 278 0.5× 469 0.8× 73 4.0k
John R. Glowa United States 36 2.8k 0.9× 1.5k 0.6× 160 0.2× 460 0.8× 542 1.0× 96 4.4k
Ian P. Stolerman United Kingdom 52 5.2k 1.7× 5.1k 2.2× 287 0.4× 664 1.1× 1.3k 2.3× 187 8.5k

Countries citing papers authored by J. David Leander

Since Specialization
Citations

This map shows the geographic impact of J. David Leander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. David Leander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. David Leander more than expected).

Fields of papers citing papers by J. David Leander

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. David Leander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. David Leander. The network helps show where J. David Leander may publish in the future.

Co-authorship network of co-authors of J. David Leander

This figure shows the co-authorship network connecting the top 25 collaborators of J. David Leander. A scholar is included among the top collaborators of J. David Leander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. David Leander. J. David Leander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wolff, Mary C. & J. David Leander. (2003). SR141716A, a cannabinoid CB1 receptor antagonist, improves memory in a delayed radial maze task. European Journal of Pharmacology. 477(3). 213–217. 83 indexed citations
2.
Wolff, Mary C. & J. David Leander. (2000). A comparison of the behavioural effects of 5-HT2A and 5-HT2C receptor agonists in the pigeon. Behavioural Pharmacology. 11(5). 355–364. 22 indexed citations
3.
Anderson, Benjamin A., Nancy K. Harn, Marvin M. Hansen, et al.. (1999). Synthesis and anticonvulsant activity of 3-aryl-5H-2,3-benzodiazepine ampa antagonists. Bioorganic & Medicinal Chemistry Letters. 9(14). 1953–1956. 17 indexed citations
4.
Ornstein, Paul L., et al.. (1998). Heteroatom-substitution as a strategy for increasing the potency of competitive NMDA antagonists. Bioorganic & Medicinal Chemistry Letters. 8(4). 389–394. 16 indexed citations
5.
Wolff, Mary C. & J. David Leander. (1998). Selective serotonin reuptake inhibitors potentiate 8-OH-DPAT-induced stimulus control in the pigeon. European Journal of Pharmacology. 345(1). 35–39. 6 indexed citations
6.
Benvenga, Mark J. & J. David Leander. (1995). Olanzapine, an atypical antipsychotic, increases rates of punished responding in pigeons. Psychopharmacology. 119(2). 133–138. 21 indexed citations
7.
Kohn, Harold, et al.. (1994). Anticonvulsant Properties ofN‐Substituted α,α‐Diamino Acid Derivatives. Journal of Pharmaceutical Sciences. 83(5). 689–691. 26 indexed citations
8.
Mitch, Charles H., J. David Leander, Laurane G. Mendelsohn, et al.. (1993). 3,4-Dimethyl-4-(3-hydroxyphenyl)piperidines: opioid antagonists with potent anorectant activity. Journal of Medicinal Chemistry. 36(20). 2842–2850. 50 indexed citations
9.
Schoepp, Darryle D., David Lodge, John D. Millar, et al.. (1991). D,L-(Tetrazol-5-yl) glycine: a novel and highly potent NMDA receptor agonist. European Journal of Pharmacology. 203(2). 237–243. 57 indexed citations
10.
Schoepp, Darryle D., Paul L. Ornstein, Craig R. Salhoff, & J. David Leander. (1991). Neuroprotectant effects of LY 274614, a structurally novel systemically active competitive NMDA receptor antagonist. Journal of Neural Transmission. 85(2). 131–143. 37 indexed citations
11.
Kohn, Harold, et al.. (1990). Preparation and anticonvulsant activity of a series of functionalized .alpha.-aromatic and .alpha.-heteroaromatic amino acids. Journal of Medicinal Chemistry. 33(3). 919–926. 44 indexed citations
12.
Leander, J. David. (1989). Tricyclic antidepressants block N‐methyl‐d‐aspartic acid‐induced lethality in mice. British Journal of Pharmacology. 96(2). 256–258. 28 indexed citations
13.
Leander, J. David, et al.. (1988). Pharmacological Effects of Enantiomers of 4‐Amino‐N‐(α‐methylbenzyl)Benzamide, a Chemically Novel Anticonvulsant. Epilepsia. 29(1). 83–90. 13 indexed citations
14.
Zimmerman, Dennis M., Buddy E. Cantrell, J. K. SWARTZENDRUBER, et al.. (1988). Synthesis and analgesic properties of N-substituted trans-4a-aryldecahydroisoquinolines. Journal of Medicinal Chemistry. 31(3). 555–560. 13 indexed citations
15.
Leander, J. David, et al.. (1988). N-Methyl-d-aspartic acid-induced lethality in mice: selective antagonism by phencylidine-like drugs. Brain Research. 448(1). 115–120. 91 indexed citations
16.
Leander, J. David. (1988). Buprenorphine is a potent κ-opioid receptor antagonist in pigeons and mice. European Journal of Pharmacology. 151(3). 457–461. 92 indexed citations
17.
Leander, J. David, et al.. (1987). Use of beta-funaltrexamine to determine mu opioid receptor involvement in the analgesic activity of various opioid ligands.. Journal of Pharmacology and Experimental Therapeutics. 241(2). 374–378. 91 indexed citations
18.
Leander, J. David, et al.. (1983). Modification of behavioral effects of morphine, meperidine and normeperidine by naloxone and by morphine tolerance.. Journal of Pharmacology and Experimental Therapeutics. 225(2). 275–283. 12 indexed citations
19.
Leander, J. David, D. E. McMillan, & Louis S. Harris. (1975). Effects of narcotic agonists and antagonists on schedule-induced water and morphine ingestion.. Journal of Pharmacology and Experimental Therapeutics. 195(2). 271–278. 28 indexed citations
20.
Leander, J. David, D. E. McMillan, & Louis S. Harris. (1975). Schedule-induced oral narcotic self-administration: acute and chronic effects.. Journal of Pharmacology and Experimental Therapeutics. 195(2). 279–287. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. J. E. Niemegeers Breakdown of academic impact, for papers by John A. Rosecrans Breakdown of academic impact, for papers by James H. Woods Breakdown of academic impact, for papers by W. Haefely Breakdown of academic impact, for papers by James H. Woods Breakdown of academic impact, for papers by B. Kenneth Koe Breakdown of academic impact, for papers by Edward F. Domino Breakdown of academic impact, for papers by Barrett R. Cooper Breakdown of academic impact, for papers by John R. Glowa Breakdown of academic impact, for papers by Ian P. Stolerman
Rankless by CCL
2026